<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0230245.ref013">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <article-title>Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group</article-title>. 
  <source>Pediatrics</source>. 
  <year>1998</year>;
  <volume>102</volume>(
  <issue>3 Pt 1</issue>):
  <fpage>531</fpage>â€“
  <lpage>7</lpage>. .
  <?supplied-pmid 9738173?>
  <pub-id pub-id-type="pmid">9738173</pub-id>
 </mixed-citation>
</ref>
